Optimizing PTCy Dose and Timing

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Optimizing PTCy Dose and Timing	Hemic and Lymphatic Diseases, Neoplasms by Site, graft versus host disease, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, neoplasm	Active, not recruiting	Phase 1 / Phase 2	2025-12-26		NCT03983850

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015
National Institute of Neurological Disorders and Stroke (NINDS)	370

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Institutes of Health Clinical Center	Bethesda	United States	800

Clinical trials